Sign Up Today and Learn More About LongBio Pharma Stock
Invest in or calculate the value of your shares in LongBio Pharma or other pre-IPO companies through EquityZen's platform.
LongBio Pharma Stock (LOPH)
LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
About LongBio Pharma Stock
Founded
2020
Industries
Software, Artificial Intelligence, Data and Analytics
LongBio Pharma Press Mentions
Stay in the know about the latest news on LongBio Pharma
Longbio’s LP-003 receives NMPA clearance to enter clinic for food allergy
bioworld • Nov 26, 2024
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight
globenewswire • Nov 04, 2024
Longbio Pharma unveils LP-005 data | The Antibody Society posted on the topic
linkedin • May 19, 2024
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD
prnewswire • Mar 12, 2024
Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024 - DigitalMore.co
digitalmore • Mar 03, 2024
Join now and verify your accreditation status to gain access to:
- LongBio Pharma current valuation
- LongBio Pharma stock price
- Available deals in LongBio Pharma and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in LongBio Pharma stock?
Accredited investors can buy pre-IPO stock in companies like LongBio Pharma through EquityZen funds. These investments are made available by existing LongBio Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell LongBio Pharma stock?
Shareholders can sell their LongBio Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
